However, differential m6A methylation in glioma is poorly understood and warrants further investigation (29), because many studies ignore IDH1 mutation status, yield conflicting results (30, 31), or do not account for potential upstream pathways that may be influencing m6A methylation and tumor growth (27, 32, 33). The gene discussed is IDH1; the disease is central nervous system cancer.